Aware Super Pty Ltd as trustee of Aware Super Has $430,000 Holdings in Centene Corporation $CNC

Aware Super Pty Ltd as trustee of Aware Super reduced its holdings in shares of Centene Corporation (NYSE:CNC) by 42.5% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,926 shares of the company’s stock after selling 5,850 shares during the quarter. Aware Super Pty Ltd as trustee of Aware Super’s holdings in Centene were worth $430,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. GAMMA Investing LLC boosted its stake in Centene by 55.7% in the 1st quarter. GAMMA Investing LLC now owns 6,095 shares of the company’s stock valued at $370,000 after purchasing an additional 2,181 shares during the period. Wealth Enhancement Advisory Services LLC boosted its position in shares of Centene by 49.6% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 136,178 shares of the company’s stock valued at $8,267,000 after acquiring an additional 45,163 shares during the period. Brighton Jones LLC bought a new stake in Centene in the 1st quarter valued at about $324,000. Janney Montgomery Scott LLC grew its position in shares of Centene by 48.1% during the 1st quarter. Janney Montgomery Scott LLC now owns 49,468 shares of the company’s stock worth $3,003,000 after purchasing an additional 16,068 shares in the last quarter. Finally, Grove Bank & Trust raised its position in shares of Centene by 2.5% in the first quarter. Grove Bank & Trust now owns 11,319 shares of the company’s stock valued at $687,000 after buying an additional 280 shares in the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Stock Down 1.8%

Shares of NYSE CNC opened at $35.78 on Thursday. The company has a 50 day simple moving average of $31.76 and a 200 day simple moving average of $44.11. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. Centene Corporation has a 1 year low of $25.08 and a 1 year high of $70.11. The firm has a market cap of $17.57 billion, a PE ratio of 8.86, a price-to-earnings-growth ratio of 1.43 and a beta of 0.48.

Centene (NYSE:CNC) last announced its quarterly earnings results on Friday, July 25th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.39). Centene had a net margin of 1.15% and a return on equity of 9.57%. The business had revenue of $48.74 billion during the quarter, compared to analyst estimates of $44.71 billion. During the same quarter last year, the company posted $2.42 earnings per share. The company’s revenue was up 22.4% compared to the same quarter last year. Centene has set its FY 2025 guidance at 1.750-1.750 EPS. On average, research analysts forecast that Centene Corporation will post 6.86 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on CNC. UBS Group cut their target price on Centene from $45.00 to $31.00 and set a “neutral” rating for the company in a research report on Monday, July 28th. Mizuho lifted their price objective on shares of Centene from $28.00 to $40.00 and gave the company a “neutral” rating in a research note on Thursday, October 9th. Wells Fargo & Company set a $41.00 target price on Centene and gave the stock an “equal weight” rating in a research note on Tuesday, October 7th. TD Cowen restated a “hold” rating and set a $33.00 price objective (down from $73.00) on shares of Centene in a research report on Monday, July 21st. Finally, JPMorgan Chase & Co. lowered their target price on Centene from $48.00 to $30.00 and set a “neutral” rating for the company in a research note on Tuesday, July 29th. Three equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $39.50.

Insider Transactions at Centene

In related news, CEO Sarah London purchased 19,230 shares of the firm’s stock in a transaction dated Friday, August 8th. The stock was bought at an average price of $25.50 per share, with a total value of $490,365.00. Following the completion of the purchase, the chief executive officer owned 845,275 shares in the company, valued at approximately $21,554,512.50. This represents a 2.33% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Theodore R. Samuels II acquired 9,000 shares of the business’s stock in a transaction that occurred on Monday, July 28th. The stock was bought at an average cost of $27.62 per share, for a total transaction of $248,580.00. Following the completion of the purchase, the director owned 32,000 shares of the company’s stock, valued at $883,840. This trade represents a 39.13% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.36% of the company’s stock.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.